Sarah Dumont

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir, Thomas Brodowicz, Antoîne Italiano et al. · The Lancet Oncology · 2016 · 276 citations

Oncology, Metronomic Therapy, Clinical Trials +5

Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial

Olivier Mir, Marie Ferrua, A. Fourcade et al. · Nature Medicine · 2022 · 132 citations · Full text

Oncology, Remote Patient Monitoring, Cancer Management +14

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Silvia Stacchiotti, Antonio López–Pousa et al. · The Lancet Oncology · 2018 · 131 citations

Surgical Oncology, Medicine, Metronomic Therapy +5

Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin

Aziz Zaanan, Peggy Cuillière-Dartigues, Agathe Guilloux et al. · Annals of Oncology · 2009 · 130 citations

Medicine, P53 Expression, Colorectal Cancer +7

Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer

Noël J.‐M. Raynal, Justin T. Lee, Youjun Wang et al. · Cancer Research · 2016 · 108 citations · Full text

Cancer Research, Chromatin, Cell Regulation +14